Substance P-Neurokinin-1 receptor interaction upregulates monocyte tissue factor

Journal of Neuroimmunology

Volumn 242, Issue 1-2, 2012, Pages 1-8

  Khan, Mohammad M ^a   Douglas, Steven D ^a,b   Benton, Tami D ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cytokines; Neurokinin receptors; Substance P; Tachykinin; Thrombosis; Tissue factor

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; NEUROKININ 1 RECEPTOR; SUBSTANCE P; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; INHIBITION KINETICS; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

BLOOD COAGULATION FACTORS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERFERON-GAMMA; MONOCYTES; NEUROPEPTIDES; RECEPTORS, NEUROKININ-1; SUBSTANCE P; THROMBOPLASTIN; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84856780895     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.10.012     Document Type: Article

References (43)

1. Andre P., Prasad K.S., Denis C.V., He M., Papalia J.M., Hynes R.O., Phillips D.R., Wagner D.D. CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat. Med. 2002, 8:247-252.
2. Azma T., Matsubara Y., Kinoshita H., Hidaka I., Shiraishi S., Nakao M., Kawamoto M., Yuge O., Yoshio Hatano Prothrombotic roles of substance-P, neurokinin-1 receptors and leukocytes in the platelet-dependent clot formation in whole blood. J. Thromb. Thrombolysis 2009, 27(3):280-286.
3. Blume J., Douglas S.D., Evans D.L. Immune suppression and immune activation in depression. Brain Behav. Immun. 2011, 25(2):221-229.
4. Bost K.L. Tachykinin-mediated modulation of the immune response. Front. Biosci. 2004, 9:3331-3332.
5. Bozic C.R., Lu B., Höpken U.E., Gerard C., Gerard N.P. Neurogenic amplification of immune complex inflammation. Science 1996, 20(273(5282)):1722-1725.
6. Bremer A.A., Leeman S.E. Substance P. Encyclopedia of Life Sciences 2010, 1-16. John Wiley & Sons, Ltd, Chichester. UK.
7. Bunce M.W., Toso R., Camire R.M. Zymogen-like factor Xa variants restore thrombin generation and effectively bypass the intrinsic pathway in vitro. Blood 2011, 117(1):290-298.
8. Chernova I., Lai J.P., Li H., Schwartz L., Tuluc F., Korchak H.M., Douglas S.D., Kilpatrick L.E. Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1-R). J. Leukocyte Biol. 2009, 85:154-164.
9. DeForge L.E., Kenney J.S., Jones M.L., Warren J.S., Remick D.G. Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. Separation of LPS- and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies. J. Immunol. 1992, 148(7):2133-2141.
10. Douglas S.D., Leeman S.E. Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation. Ann. N. Y. Acad. Sci. 2011, 1217:83-95.
11. Douglas S.D., Ho W.Z., Gettes D.R., Cnaan A., Zhao H., Leserman J., Petitto J.M., Golden R.N., Evans D.L. Elevated substance P levels in HIV infected men. AIDS 2001, 15:2043-2045.
12. Douglas S.D., Cnaan A., Lynch K.G., Benton T., Zhao H., Gettes D.R., Evans D.L. Elevated substance P levels in HIV infected women in comparison to HIV-negative women. AIDS Res. Hum. Retroviruses 2008, 24:375-378.
13. Drake T.A., Cheng J., Chang A., Taylor F.B. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am. J. Pathol. 1993, 142:1458-1470.
14. Fong T.M., Anderson S.A., Yu H., Huang R.R., Strader C.D. Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor. Mol. Pharmacol. 1992, 41:24-30.
15. Fundeburg N.T., Mayne E., Sieg S.F., Asaad R., Jiang W., Kalinowska M., Luciano A.A., Stevens W., Rodriguez B., Brenchley J.M., Douek D.C., Lederman M.M. Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. Blood 2010, 115:161-167.
16. Hemker H.C., Giesen P., Al Dieri R., Regnault V., de Smedt E., Wagenvoord R., Lecompte T., Béguin S. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol. Haemost. Thromb. 2003, 33(1):4-15.
17. Ho W.Z., Lai J.P., Zhu X.H., Uvaydova M., Douglas S.D. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J. Immunol. 1997, 159:5654-5660.
18. Ho W.Z., Lai J.P., Li Y., Douglas S.D. HIV enhances substance P expression in human immune cells. FASEB J. 2002, 16(6):616-618.
19. Hurtado B., de Frutos P.G. GAS6 in systemic inflammatory diseases: with and without infection. Crit. Care 2010, 14(5):1003.
20. Jones S., Tucker K.L., Sage T., William J., Kaiser W.J., Barrett N.E., Lowry P.J., Zimmer A., Hunt S.P., Emerson M., Gibbins J.M. Peripheral tachykinins and the neurokinin receptor NK1 are required for platelet thrombus formation. Blood 2008, 111(2):605-612.
21. Kashiwagi H., Shiraga M., Kato H., Kamae T., Yamamoto N., Tadokoro S., Kurata Y., Tomiyama Y., Kanakura Y. Negative regulation of platelet function by a secreted cell repulsive protein, semaphorin 3A. Blood 2005, 106:913-921.
22. Key N.S., Slungaard A., Dandelet L., Nelson S.C., Moertel C., Styles L.A., Kuypers F.A., Bach R.R. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood 1998, 91:4216-4223.
23. Khan M.M., Bradford H.N., Isordia-Salas I., Yuchuan Liu, Yi Wu., Espinola R.G., Ghebrehiwet B., Colman R.W. High molecular weight kininogen fragments stimulate the secretion of cytokines and chemokines through uPAR, Mac-1 and gC1qR in monocyte. Arterioscler. Thromb. Vasc. Biol. 2006, 26:2260-2266.
24. Khan M.M.H., Liu Y., Khan M.E., Gilman M.L., Khan S.T., Bromberg M.E., Colman R.W. Upregulation of tissue factor in monocytes by cleaved high molecular weight kininogen is dependent on TNFα and IL-1β. Am. J. Physiol. Heart Circ. Physiol. 2010, 298:H652-H658.
25. Khawaja A.M., Rogers D.F. Tachykinins: receptor to effector. Int. J. Biochem. Cell Biol. 1996, 28:721-738.
26. Lai J.P., Douglas S.D., Ho W.Z. Human lymphocytes express substance P and its receptor. J. Neuroimmunol. 1998, 86(1):80-86.
27. Lai J.P., Ho W.Z., Zhan G.X., Yi Y., Collman R.G., Douglas S.D. Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(7):3970-3975.
28. Lai J.P., Ho W.Z., Kilpatrick L.E., Wang X., Tuluc F., Korchak H.M., Douglas S.D. Full-length and truncated neurokinin-1 receptor expression and function during monocyte/macrophage differentiation. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(20):7771-7776.
29. Lucey D.R., Novak J.M., Polonis V.R., Liu Y., Gartner S. Characterization of substance P binding to human monocytes/macrophages. Clin. Diagn. Lab. Immunol. 1994, 1:330-335.
30. Marriott I., Bost K.L. Substance P receptor mediated macrophage responses. Adv. Exp. Med. Biol. 2001, 493:247-254.
31. Michaels L.A., Ohene-Frempong K., Zhao H., Douglas S.D. Serum levels of substance P are elevated in patients with sickle cell disease and increase further during vaso-occlusive crisis. Blood 1998, 92(9):3148-3151.
32. Payan D.G., Brewster D.R., Missirian-Bastian A., Goetzl E.J. Substance P recognition by a subset of human T lymphocytes. J. Clin. Invest. 1984, 74:1532-1539.
33. Prevost N., Woulfe D., Tanaka T., Brass L.F. Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:9219-9224.
34. Roger T., Bresser P., Snoek M., van der Sluijs K., van den Berg A., Nijhuis M., Jansen H.M., Lutter R. Exaggerated IL-8 and IL-6 responses to TNF-alpha by parainfluenza virus type 4-infected NCI-H292 cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 287(5):L1048-L1055.
35. Satake H., Kawada T. Overview of the primary structure, tissue distribution, and functions of tachykinins and their receptors. Curr. Drug Targets 2006, 7:963-974.
36. Shanahan F., Denburg J.A., Fox J., Bienenstock J., Befus D. Mast cell heterogeneity: effects of neuroenteric peptides on histamine release. J. Immunol. 1985, 135:1331-1337.
37. Stanisz A.M., Scicchitano R., Dazin P., Bienenstock J., Payan D.G. Distribution of substance P receptors on murine spleen and Peyer's patch T and B cells. J. Immunol. 1987, 139:749-754.
38. Tuluc F., Lai J.P., Kilpatrick L.E., Evans D.L., Douglas S.D. Neurokinin 1 receptor isoforms and the control of innate immunity. Trends Immunol. 2009, 30:271-276.
39. Turner R.J., Helps S.C., Thornton E., Vink R. A substance P antagonist improves outcome when administered 4 h after onset of ischaemic stroke. Brain Res. 2011, 1393:84-90.
40. Van den Berg Y.W., Versteeg H.H. Alternatively spliced tissue factor. A crippled protein in coagulation or a key player in non-haemostatic processes?. Hamostaseologie 2010, 30(3):144-149.
41. Wozniak A., McLennan G., Betts W.H., Murphy G.A., Scicchitano R. Activation of human neutrophils by substance P: effect on fMLPstimulated oxidative and arachidonic acid metabolism and on antibodydependent cell-mediated cytotoxicity. Immunology 1989, 68:359-364.
42. Zhang Y., Berger A., Milne C.D., Paige C.J. Tachykinins in the immune system. Curr. Drug Targets 2006, 7:1011-1020.
43. Zhu L., Bergmeier W., Wu J., Jiang H., Stalker T.J., Cieslak M., Fan R., Boumsell L., Kumanogoh A., Kikutani H., Tamagnone L., Wagner D.D., Milla M.E., Brass L.F. Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:1621-1626.